Cited by 534Acute Myeloid Leukemia ResearchCancer Genomics and DiagnosticsBlood disorders and treatments

Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis

Open access
McKerrell, Thomas, Park, Naomi, Moreno, Thaidy, Grove, Carolyn S., Ponstingl, Hannes, Stephens, Jonathan, Crawley, Charles, Craig, Jenny +10 more·2015·Cell Reports

Abstract

Clonal hemopoiesis driven by leukemia-associated gene mutations can occur without evidence of a blood disorder. To investigate this phenomenon, we interrogated 15 mutation hot spots in blood DNA from 4,219 individuals using ultra-deep sequencing. Using only the hot spots studied, we identified clonal hemopoiesis in 0.8% of individuals under 60, rising to 19.5% of those ≥90 years, thus predicting that clonal hemopoiesis is much more prevalent than previously realized. DNMT3A-R882 mutations were most common and, although their prevalence increased with age, were found in individuals as young as 25 years. By contrast, mutations affecting spliceosome genes SF3B1 and SRSF2, closely associated with the myelodysplastic syndromes, were identified only in those aged >70 years, with several individuals harboring more than one such mutation. This indicates that spliceosome gene mutations drive clonal expansion under selection pressures particular to the aging hemopoietic system and explains the high incidence of clonal disorders associated with these mutations in advanced old age.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2015.02.005

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Subsequent studies in healthy persons using more sensitive approaches have found the prevalence of clonal hematopoiesis to be much higher than initial whole-exome sequencing studies.

    “Subsequent studies in healthy persons using more sensitive approaches have found the prevalence of clonal hematopoiesis to be much higher, although the biological significance of the smaller clones is unknown 31–33.”

    From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [31]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 39 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
McKerrell, T., Park, N., Moreno, T., Grove, C. S., Ponstingl, H., Stephens, J., Crawley, C., Craig, J., Scott, M. A., Hodkinson, C., Baxter, J., Rad, R., Forsyth, D. R., Quail, M. A., Zeggini, E., Ouwehand, W., Varela, I., & Vassiliou, G. S.
Affiliations
  • Wellcome Sanger Institute (GB)
  • NHS Blood and Transplant (GB)
  • Cambridge University Hospitals NHS Foundation Trust (GB)
  • University of Cambridge (GB)
  • German Cancer Research Center (DE)
  • Universidad de Cantabria (ES)
Corresponding author
Vassiliou, George S.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2015-03
Volume
10
Issue
8
Pages
1239-1245
ISSN
2211-1247 (ISSN-L)
OpenAlex
W2073440691
Cited by
534
References
39
Citations by year
2026: 26 · 2025: 36 · 2024: 33 · 2023: 48 · 2022: 43 · 2021: 45 · 2020: 52 · 2019: 49 · 2018: 65 · 2017: 64 · 2016: 43 · 2015: 29 · 2014: 1
FWCI
52.68
Type
journal article
Language
en
Open access
Locations
  • Cell Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UCrea (University of Cantabria) (publishedVersion, cc-by)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by-nc-nd)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
  • Apollo (cc-by)
Funders
  • Foundation for the National Institutes of Health
  • Celgene
  • University of Essex
  • Wellcome Trust (WT061858, 061858, 095663, WT 098051, 100678/Z/12/Z, WT095663MA, 076113, 076113/C/04/Z)
  • Understanding Society
  • National Institute for Health and Care Research (NF-SI-0510-10214, RP-PG-0310-1002, NF-SI-0513-10151)
  • British Heart Foundation (RG/09/012/28096)
  • Leukaemia and Lymphoma Research
  • Ministerio de Economía y Competitividad
  • Economic and Social Research Council (ES/H029745/1)
  • Research England
  • NIHR Cambridge Biomedical Research Centre
  • Common Fund
Topics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Blood disorders and treatments
Keywords
somatic mutations, SF3B1, SRSF2, spliceosome mutations, aging, clonal expansion, myelodysplastic syndrome, mutational hotspots, hematopoietic stem cells
MeSH terms
Serine-Arginine Splicing Factors, RNA Splicing Factors, DNA Methyltransferase 3A, Adolescent, Adult, Aged, Aged, 80 and over, Aging, DNA (Cytosine-5-)-Methyltransferases, Hematopoiesis, Humans, Leukemia, Middle Aged, Mutation, Myelodysplastic Syndromes, Nuclear Proteins, Phosphoproteins, Ribonucleoproteins, Ribonucleoprotein, U2 Small Nuclear, Sequence Analysis, DNA, Computational Biology, Young Adult, High-Throughput Nucleotide Sequencing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review